184 related articles for article (PubMed ID: 37296410)
21. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
[TBL] [Abstract][Full Text] [Related]
22. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
[TBL] [Abstract][Full Text] [Related]
23. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
24. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
[TBL] [Abstract][Full Text] [Related]
25. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
[No Abstract] [Full Text] [Related]
26. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of mineralocorticoid receptor antagonist in patients with heart failure with preserved ejection fraction.
Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
ESC Heart Fail; 2020 Oct; 7(5):2752-2761. PubMed ID: 32592265
[TBL] [Abstract][Full Text] [Related]
28. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
Park JJ; Cho YJ; Oh IY; Park HA; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
Int J Cardiol; 2017 Dec; 248():239-245. PubMed ID: 28821416
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
Bonsu KO; Owusu IK; Buabeng KO; Reidpath DD; Kadirvelu A
Int J Cardiol; 2017 Jul; 238():128-135. PubMed ID: 28318656
[TBL] [Abstract][Full Text] [Related]
30. Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60.
Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Seo M; Yano M; Hayashi T; Nakagawa Y; Tamaki S; Yamada T; Kurakami H; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
J Am Heart Assoc; 2022 Aug; 11(15):e025300. PubMed ID: 35904209
[TBL] [Abstract][Full Text] [Related]
31. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
Zhang X; Lv X; Wang N; Yu S; Si J; Zhang Y; Cai M; Liu Y
Int J Cardiol; 2023 Aug; 385():34-40. PubMed ID: 37257517
[TBL] [Abstract][Full Text] [Related]
32. A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population.
Han Y; Lu J; Chen B; Li X; Dai H; Zhang L; Yan X; Liu J; Zhang H; Fu X; Yu Q; Ren J; Cui H; Gao Y; Li J
Eur J Prev Cardiol; 2023 Sep; 30(13):1382-1390. PubMed ID: 37343143
[TBL] [Abstract][Full Text] [Related]
33. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis.
Wang AY; Wang M; Lam CW; Chan IH; Lui SF; Sanderson JE
Am J Kidney Dis; 2013 Jun; 61(6):975-83. PubMed ID: 23474006
[TBL] [Abstract][Full Text] [Related]
34. Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy.
Liu J; Wang D; Ruan J; Wu G; Xu L; Jiang W; Wang J; Sun X; Kang L; Song L
BMC Med; 2022 Jan; 20(1):21. PubMed ID: 35078475
[TBL] [Abstract][Full Text] [Related]
35. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.
Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2021 Jan; 9(1):13-24. PubMed ID: 33189633
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of serum hyponatremia for outcomes in patients with heart failure with preserved ejection fraction: An observational cohort study.
Su Y; Ma M; Zhang H; Pan X; Zhang X; Zhang F; Lv Y; Yan C
Exp Ther Med; 2020 Nov; 20(5):101. PubMed ID: 32973950
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.
Vazir A; Claggett B; Pitt B; Anand I; Sweitzer N; Fang J; Fleg J; Rouleau J; Shah S; Pfeffer MA; Solomon SD
JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132
[TBL] [Abstract][Full Text] [Related]
39. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
40. Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF]).
Chung S; Kim TH; Uhm JS; Cha MJ; Lee JM; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Kim CS; Lee YS; Shim J; Joung B
Am J Cardiol; 2020 Jan; 125(1):68-75. PubMed ID: 31699363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
